Bio Medica Laboratories IPO Details
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ā¹10 Per Equity Share |
| IPO Price Band | ā¹132 to ā¹139 Per Share |
| Issue Size | Approx ā¹52.43 Crores, 37,72,000 Equity Shares |
| Fresh Issue | Approx ā¹47.19 Crores, 33,95,000 Equity Shares |
| Offer for Sale: | Approx ā¹5.24 Crores, 3,77,000 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Bio Medica Laboratories IPO Review & Key Points
- Review:
Bio Medica Laboratories IPO Market Lot
The Bio Medica Laboratories IPO minimum market lot is 2,000 shares with ā¹2,78,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ā¹2,78,000 |
| Retail Maximum | 2 | 2,000 | ā¹2,78,000 |
| S-HNI Minimum | 3 | 3,000 | ā¹4,17,000 |
| S-HNI Maximum | 7 | 7,000 | ā¹9,73,000 |
| B-HNI Minimum | 8 | 8,000 | ā¹11,12,000 |
IPO Reservation
| Investor Category | Share Offered | Shares (%) |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 36,000 Shares | 0.95% |
| NII Shares Offered | 17,55,000 Shares | 46.53% |
| Retail Shares Offered | 17,92,000 Shares | 47.51% |
Bio Medica Laboratories IPO Dates
The Bio Medica Laboratories IPO date is May 21 and the close date is May 25. The Bio Medica Laboratories IPO allotment will be finalized on May 26 and the IPO listing on May 29.
| IPO Open Date: | May 21, 2026 |
| IPO Close Date: | May 25, 2026 |
| Basis of Allotment: | May 26, 2026 |
| Refunds: | May 27, 2026 |
| Credit to Demat Account: | May 27, 2026 |
| IPO Listing Date: | May 29, 2026 |
| IPO Bidding Cut-off Time: | May 25, 2026 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Mr. Mukesh Mehta and Mr. Pradeep Mehta.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 91,80,001 | 99.99% |
| Promoter Holding Post Issue | 1,25,74,801 | -% |
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
| Repayment of Loan | ā¹7.25 |
| Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises | ā¹24.81 |
| General Corporate Purpose | ā¹- |
About Bio Medica Laboratories IPO
Bio Medica Laboratories is one of the leading manufacturers of parenteral medicines (injectable products) in India. The firm has been involved in developing a wide range of parenteral medicines targeting both human and animal needs. They manufacture generic medicines in the form of Liquid injections and dry powder injections, which come in various forms of packaging like ampoules and vials.
The company also claims to offer high-quality and safe products, followed by Good Manufacturing Practices (GMP and GLP). Moreover, the company has built a reputation for providing reliable yet effective solutions in the healthcare industry. Its product range includes injectables for the domestic market, Injectables for export, and Injectables for veterinary.
Bio Medica Laboratories IPO Company Financial Report
Amount ā¹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ā¹16.25 | ā¹15.80 | ā¹0.33 | ā¹17.57 |
| 2024 | ā¹15.34 | ā¹11.69 | ā¹2.50 | ā¹19.53 |
| 2025 | ā¹38.33 | ā¹25.18 | ā¹9.79 | ā¹39.12 |
| Nov 2025 | ā¹28.63 | ā¹16.95 | ā¹8.66 | ā¹65.17 |
Bio Medica Laboratories IPO Valuation – FY2025
Check Bio Medica Laboratories IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 99.59% |
| ROCE: | 48.20% |
| EBITDA Margin: | 39.83% |
| PAT Margin: | 25.64% |
| Debt to equity ratio: | 1.02 |
| Earning Per Share (EPS): | ā¹10.67 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 99.59% |
| Net Asset Value (NAV): | ā¹16.05 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Zenotech Laboratories Limited | 0.92 | – | 6.01% | 15.76 | 5.61 Cr. |
| Shukra Pharmaceuticals Limited | 0.22 | 47.57 | 15.90% | 1.43 | 9.58 Cr. |
IPO Lead Managers aka Merchant Bankers
- Narnolia Financial Services Ltd.
Company Address
Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: [email protected]
Website: http://www.biomedica.co.in/
IPO Registrar
Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: [email protected]
Website: https://www.skylinerta.com/ipo.php
Bio Medica Laboratories IPO FAQs
What is Bio Medica Laboratories IPO?
When Bio Medica Laboratories IPO will open for subscription?
What is Bio Medica Laboratories IPO Investors Portion?
How to Apply the Bio Medica Laboratories IPO?
What is Bio Medica Laboratories IPO Issue Size?
What is Bio Medica Laboratories IPO Price Band?
What is Bio Medica Laboratories IPO Lot Size?
What is the Bio Medica Laboratories IPO Allotment Date?
What is the Bio Medica Laboratories IPO Listing Date?
Note: The Bio Medica Laboratories IPO price band and date are officially announced. The (Bio Medica Laboratories IPO grey market premium) will be added to the IPO GMP page as it will start).
